C17ORF75 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.540600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.607400E-01
Normal-vs-Stage2
5.984600E-01
Normal-vs-Stage3
1.529670E-02
Normal-vs-Stage4
4.824600E-01
Stage1-vs-Stage2
7.729800E-02
Stage1-vs-Stage3
2.840000E-02
Stage1-vs-Stage4
2.630600E-01
Stage2-vs-Stage3
8.760200E-02
Stage2-vs-Stage4
9.820000E-01
Stage3-vs-Stage4
3.860000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.554200E-01
Normal-vs-AfricanAmerican
8.273000E-01
Normal-vs-Asian
8.854400E-01
Caucasian-vs-AfricanAmerican
7.125800E-01
Caucasian-vs-Asian
5.832000E-01
AfricanAmerican-vs-Asian
7.054400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.842000E-01
Normal-vs-Female
9.757600E-01
Male-vs-Female
6.573500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.885200E-01
Normal-vs-Age(41-60Yrs)
8.652800E-01
Normal-vs-Age(61-80Yrs)
7.074200E-01
Normal-vs-Age(81-100Yrs)
4.437400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.337200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.354600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.523600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.095000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.313800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.290400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.511440E-01
Normal-vs-Daily Drinker
4.520200E-01
Normal-vs-Weekly Drinker
6.781600E-02
Normal-vs-Occasional Drinker
7.794800E-01
Normal-vs-Social Drinker
7.819600E-01
Non Drinker-vs-Daily Drinker
4.343400E-01
Non Drinker-vs-Weekly Drinker
4.272400E-01
Non Drinker-vs-Occasional Drinker
2.578300E-02
Non Drinker-vs-Social Drinker
6.796000E-02
Daily Drinker-vs-Weekly Drinker
2.228800E-01
Daily Drinker-vs-Occasional Drinker
7.969700E-02
Daily Drinker-vs-Social Drinker
1.538430E-01
Weekly Drinker-vs-Occasional Drinker
1.094120E-02
Weekly Drinker-vs-Social Drinker
3.610300E-02
Occasional Drinker-vs-Social Drinker
9.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.296000E-01
Normal-vs-Grade 2
2.166600E-01
Normal-vs-Grade 3
1.954250E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.327590E-01
Grade 1-vs-Grade 3
2.969800E-01
Grade 1-vs-Grade 4
2.296000E-01
Grade 2-vs-Grade 3
2.791800E-01
Grade 2-vs-Grade 4
2.166600E-01
Grade 3-vs-Grade 4
1.954250E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.277000E-01
Normal-vs-NonDiabetic
8.833600E-01
Diabetic-vs-NonDiabetic
2.401800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.606200E-01
Normal-vs-NoPancreatitis
7.771200E-01
Pancreatitis-vs-NoPancreatitis
4.345600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.845200E-01
Normal-vs-N1
6.100200E-01
N0-vs-N1
1.097560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.246000E-01
Normal-vs-TP53-NonMutant
9.100800E-01
TP53-Mutant-vs-TP53-NonMutant
9.688000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
